Authors: GEYER RE

Citation: Re. Geyer, EXTRALABEL DRUG-USE AND COMPOUNDING IN VETERINARY-MEDICINE, Food and drug law journal, 52(3), 1997, pp. 291-295

Authors: GLOYD J MITCHELL B POWERS T BARROWS T NASH D SIEGNER W ROGERS M TESKE R DUDLEY S SHELDON J LENZ T OELLER D GEYER RE BAGLEY C

Citation: J. Gloyd et al., COMPOUNDING FOR TREATMENT OF TOXICOSIS - DISCUSSION, Journal of the American Veterinary Medical Association, 205(2), 1994, pp. 217-220

Authors: GEYER RE

Citation: Re. Geyer, LEGAL RESTRICTIONS ON COMPOUNDING, Journal of the American Veterinary Medical Association, 205(2), 1994, pp. 241-242

Authors: TESKE R BARROWS T GEYER RE SIEGNER W TERRY M NEWTON D SEARS JE GLOYD J RIVIERE J HARDEE GE POWERS T SHELDON J

Citation: R. Teske et al., LABELING AND RECORD-KEEPING FOR COMPOUNDED DRUGS - DISCUSSION, Journal of the American Veterinary Medical Association, 205(2), 1994, pp. 250-253

Authors: GEYER RE

Citation: Re. Geyer, IMPLICATIONS FOR THE FDA CENTER FOR VETERINARY-MEDICINE (CVM), Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1718-1719

Authors: POWERS T GEYER RE REID J SUNDLOF S WILKES D BOOTHE D TESKE RH BRUMBAUGH G BROWN S ADAMS JB LEIN D SWANSON R

Citation: T. Powers et al., IMPLICATIONS FOR THE FDA CENTER FOR VETERINARY-MEDICINE (CVM) - QUESTIONS AND ANSWERS, Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1720-1723